Product Information
TOBREX 0.3% EYE OINTMENT is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $84.5164 per GM under NDC 00078081301. Its NADAC has been published 207 times since Sep 7, 2022.
FDA first approved this application before 1982.
The High Outlier badge above means this manufacturer's average price in the tobramycin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/g
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078081301
Classification
Brand
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCINApproval Type
New Drug (NDA)
FDA Application
NDA050555FDA Approved
Before 1982
On Market Since
6/28/1981
Pharmacological Classes
Price Statistics
The NADAC for TOBREX 0.3% EYE OINTMENT has been published 207 times since Sep 7, 2022, and over the history we have for it it has risen 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $84.5164 per GM |
|---|---|
| All-time high | $84.7026 (Jun 10, 2026) |
| All-time low | $61.5927 (Sep 7, 2022) |
| 52-week high | $84.7026 |
| 52-week low | $76.4120 |
| Median price | $70.0225 |
| Average price | $72.5761 |
| Largest weekly change | +9.9% (Jan 14, 2026) |
| Weeks tracked | 207 |
| Tracking since | Sep 7, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tobramycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBREX 0.3% EYE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TOBREX 0.3% EYE OINTMENT, manufactured by Novartis Pharmaceuticals Corporation, is $84.5164 per GM (NDC 00078081301), effective Aug 19, 2026.
How has the price of TOBREX 0.3% EYE OINTMENT changed over time?
Over the history we have for it, the NADAC for TOBREX 0.3% EYE OINTMENT has risen 37.2%. It has been tracked across 207 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for TOBREX 0.3% EYE OINTMENT?
Since Sep 7, 2022, the NADAC for TOBREX 0.3% EYE OINTMENT has ranged from a low of $61.5927 (Sep 7, 2022) to a high of $84.7026 (Jun 10, 2026), with a median of $70.0225 per GM.
Are there cheaper alternatives to TOBREX 0.3% EYE OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of TOBREX 0.3% EYE OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOBREX 0.3% EYE OINTMENT?
TOBREX 0.3% EYE OINTMENT (NDC 00078081301) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.